| 000 | 01818 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514043725.0 | ||
| 264 | 0 | _c20021011 | |
| 008 | 200210s 0 0 eng d | ||
| 022 | _a0026-895X | ||
| 024 | 7 |
_a10.1124/mol.62.4.936 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSuschek, Christoph Viktor | |
| 245 | 0 | 0 |
_aRevisiting an old antimicrobial drug: amphotericin B induces interleukin-1-converting enzyme as the main factor for inducible nitric-oxide synthase expression in activated endothelia. _h[electronic resource] |
| 260 |
_bMolecular pharmacology _cOct 2002 |
||
| 300 |
_a936-46 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAmphotericin B _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntifungal Agents _xpharmacology |
| 650 | 0 | 4 |
_aCaspase 1 _xbiosynthesis |
| 650 | 0 | 4 |
_aCytokines _xmetabolism |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
| 650 | 0 | 4 |
_aEnzyme Induction _xdrug effects |
| 650 | 0 | 4 |
_aGene Expression _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukin-1 _xmetabolism |
| 650 | 0 | 4 |
_aNitric Oxide Synthase _xbiosynthesis |
| 650 | 0 | 4 | _aNitric Oxide Synthase Type II |
| 650 | 0 | 4 |
_aPromoter Regions, Genetic _xphysiology |
| 650 | 0 | 4 |
_aRNA, Messenger _xbiosynthesis |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xmetabolism |
| 700 | 1 | _aBonmann, Eckhard | |
| 700 | 1 | _aKapsokefalou, Anna | |
| 700 | 1 | _aHemmrich, Karsten | |
| 700 | 1 | _aKleinert, Hartmut | |
| 700 | 1 | _aFörstermann, Ulrich | |
| 700 | 1 | _aKröncke, Klaus-Dietrich | |
| 700 | 1 | _aMahotka, Csaba | |
| 700 | 1 | _aKolb-Bachofen, Victoria | |
| 773 | 0 |
_tMolecular pharmacology _gvol. 62 _gno. 4 _gp. 936-46 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1124/mol.62.4.936 _zAvailable from publisher's website |
| 999 |
_c12116473 _d12116473 |
||